LianBio announces topline results from phase III LIBRA trial of TP 03 in Chinese patients with Demodex blepharitis
LianBio a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, announced topline results from the Phase III LIBRA clinical trial… read more.
